As a result of the everchanging pharmaceutical environment Servier Canada Inc. ("Servier") has taken steps to adapt the way it conducts its activities, including, but not limited to the methods of communication it uses with its customers and business partners.
While face-to-face meetings remain the preferred method of communication, Servier will be increasingly leveraging digital technologies to communicate with and support its customers and business partners.
In order for you to benefit from these new methods of communication, Servier is seeking your consent to be contacted by Servier, from time to time, including by electronic communication, to receive information that may be of interest to you, including but not limited to information about products, disease information, treatment options, educational programs, other learning activities, and patient support programs.
